VA-SES
3.6.2021 08:52:10 CEST | Business Wire | Press release
SES Government Solutions (SES GS), a wholly-owned subsidiary of SES, and Isotropic Systems, a leading developer of transformational broadband terminal technologies, announce the successful completion of the first of two milestone next-generation antenna trials with the U.S. Military aimed at unleashing unprecedented information distribution to warfighters across the battlefield.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210602006167/en/
The U.S. Air Force and U.S. Army, through the innovative Defense Experimentation Using Commercial Space Internet (DEUCSI) program, are evaluating the ability of Isotropic Systems’ optical beamforming antenna to enable frontline armed forces to access high-speed, real-time data simultaneously over multiple commercial and military satellites.
First phase dual-beam tests conducted at the Harwell Science, Technology and Innovation Campus near Oxford, UK, have successfully demonstrated transformational optics at the core of Isotropic Systems’ multi-beam terminal that are fully capable of linking with multiple satellites at the same time.
Over-the-air (OTA) trials conducted at an SES teleport in Port St. Lucie, Florida, also part of phase one, have verified the Isotropic Systems’ high-performance multi-beam platform meets military requirements to acquire and track SES’ O3b MEO satellites.
Phase two trials will test Isotropic Systems’ latest antenna prototype over links with SES satellites in geostationary orbit (GEO) and medium earth orbit (MEO), demonstrating seamless satellite-to-satellite transitions and a redundant, resilient leap in wartime communications.
The DEUCSI trials will wrap up in 2021, ahead of the commercial launch of Isotropic Systems’ optical multi-beam antenna production scheduled for 2022, and in time to support SES’ new high-throughput MEO constellation satellites coming online, the groundbreaking O3b mPOWER system.
“The armed forces and defense agencies are incredibly good at acquiring actionable information, but they run into bottlenecks when they try to distribute that mission-critical data over single beam parabolic antennas and other outdated infrastructure,” said Scott Sprague, Isotropic Systems CCO. “These milestone trials with the U.S. Army and Air Force are successfully demonstrating the multi-beam, multi-orbit connectivity and capabilities our high-performance terminals will put in the hands of frontline warfighters and decision makers across the government sector and battlespace.”
“Next-gen satellites and constellations need equally robust and resilient terminals and ground infrastructure to meet the government’s ’Fighting SATCOM’ vision,” said Pete Hoene, President and CEO of SES Government Solutions, Brigadier General, USAF (Ret.). “Interoperability and multi-orbit capabilities are essential to achieving this vision, and these collaborative trials with the armed forces demonstrate how Isotropic Systems’ multi-beam antenna can successfully deliver robust connectivity across our vast MEO and GEO fleet. Each successful phase is a prime example of how the government and commercial partners can develop capabilities in parallel, which is especially important to us as we ready to launch our O3b mPOWER constellation and SES-17 satellite this year.
“Without affecting the main communications link, the Isotropic Systems multi-beam terminal can use a second or third link to evaluate the environment to preemptively decide the best routing option at any given time to maximize performance,” explained Brian Billman, Vice President of Product Management for Isotropic Systems. “That’s the level of differentiating capabilities our terminal roadmap leads to as a result of these important trials with the U.S. military.”
For further information please contact:
About SES Government Solutions
SES Government Solutions (SES GS) is a wholly-owned subsidiary of SES, the leader in global content connectivity solutions. SES GS operates under a proxy board allowing them to provide services through contracts with the U.S. Government, including classified work. SES GS is exclusively focused on meeting the satellite communications needs of the U.S. Government. Leveraging more than four decades of experience in the government SATCOM market, SES GS offers robust and secure end-to-end satellite communications solutions. Further information can be found at www.ses-gs.com .
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
About Isotropic Systems
Isotropic Systems is developing the world’s first multi-service, high-bandwidth, low power, fully integrated high throughput terminals designed to support the satellite industry to 'reach beyond' traditional markets and acquire new customers with a full suite of high throughput services. The company’s team of industry experts and scientists has pioneered several firsts in satellite terminal design resulting in a line of terminals that are customizable to meet the performance, cost and power requirements of countless applications – from the most complex government defense systems and mobile backhaul solutions capable of extending 5G, to next-gen connected experiences aboard commercial airliners, cruise ships, offshore rigs, and even small fishing boats at sea. Isotropic Systems’ Series A funding was led by Boeing to advance space-based connectivity. Further information is available at www.isotropicsystems.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210602006167/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release
Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release
New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel
HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 17:30:00 CEST | Press release
HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
